Rivaroxaban 366789-02-8 Tsarin jini yana kare Antithrombosis
Biya:T/T, L/C
Asalin samfur:China
Tashar Jirgin Ruwa:Beijing/Shanghai/Hangzhou
Ƙarfin samarwa:200kg/wata
Oda (MOQ):25kg
Lokacin Jagora:3 Ranakun Aiki
Yanayin ajiya:Ajiye a wuri mai sanyi, busasshiyar wuri, zazzabin ɗaki.
Kunshin kayan:ganga
Girman kunshin:25kg/drum
Bayanin aminci:Ba kayan haɗari ba
Gabatarwa
Rivaroxaban, magani ne na maganin ƙwanƙwasa jini (mafi ƙarancin jini).Ana amfani dashi a cikin manya tare da fibrillation maras nauyi (sai dai fibrillation na atrial saboda cututtukan zuciya na rheumatic valvular, da kuma fibrillation na zuciya bayan maye gurbin zuciya) don rage haɗarin bugun jini da bugun jini.
Rivaroxaban, ana amfani da shi don magance da kuma hana zubar jini.
Rivaroxaban, ana amfani da f don manya marasa lafiya da ke fuskantar zaɓaɓɓen hip ko aikin maye gurbin gwiwa don hana thrombosis venous.
Ƙayyadewa (EP)
| Abu | Ƙayyadaddun bayanai |
| Bayyanar | Fari ko rawaya foda |
| Solubility | A zahiri wanda ba a iya narkewa a cikin ruwa, mai narkewa cikin yardar kaina a cikin DMSO, kusan ba zai iya narkewa cikin ethanol mai anhydrous da kuma cikin heptanes. |
| Ganewa | IR: Spectrum ya kamata ya bi WS |
| HPLC-RT na samfurin a ƙarƙashin gwajin tsabta na enantiometric yakamata ya bi na WS. | |
| Ruwa | ≤0.5% |
| Sulfate ash | ≤0.1% |
| Asarar bushewa | ≤0.5% |
| Karfe masu nauyi | ≤20ppm |
| Enantioner | Najasa A: ≤0.4% |
| Ragowar sauran ƙarfi | Ethanol: ≤5000ppm Ethyl acetate: ≤5000ppm Acetone: ≤5000ppm N, N-Dimethylformamide: ≤880ppm Methylene chloride: ≤600ppm Benzene: ≤2ppm |
| Abu mai alaƙa | Najasa B: ≤0.10% Najasa D: ≤0.10% Najasa E: ≤0.10% Najasa F: ≤0.10% Rashin tsabta G: ≤0.10% Najasa H: ≤0.10% Najasa I: ≤0.10% Najasa J: ≤0.10% RVB-4-NJSH: ≤0.10% RVB-ZA: ≤0.10% RVB-BAM: ≤0.10% RVB-ZC: ≤0.10% RVB-HBY: ≤75ppm Duk wani ƙazanta da ba a sani ba: ≤0.10% Jimlar ƙazanta: ≤0.3% |
| Rarraba girman barbashi | D10:/ D50: D90:/ |
| Assay (anhydrous abu) | 98.0-102.0 |
